for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Prim SA

PRIM.MC

Latest Trade

12.20EUR

Change

0.10(+0.83%)

Volume

12,875

Today's Range

11.90

 - 

12.20

52 Week Range

10.60

 - 

12.50

As of on the Mercado Continuo Espana ∙ Minimum 15 minute delay

Pricing

Previous Close
12.10
Open
12.20
Volume
12,875
3M AVG Volume
0.06
Today's High
12.20
Today's Low
11.90
52 Week High
12.50
52 Week Low
10.60
Shares Out (MIL)
17.33
Market Cap (MIL)
206.43
Forward P/E
--
Dividend (Yield %)
4.86

Next Event

Prim SA Annual Shareholders Meeting

Latest Developments

More

Prim To Pay Gross Dividend Of 0.11 Eur/Shr On Jan. 16

Prim SA 9-Month Net Profit Down At 6.8 Mln Euros YoY

Prim H1 Net Profit Down At 5.4 Mln Euros YoY

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Prim SA

Prim SA is a Spain-based company principally engaged in the provision of hospital supplies. The Company’s products portfolio comprises implantable orthopedic products, silicone foot products, abduction splints, mastectomy lingerie, prosthetic components, as well as articulated electric beds and various types of accessories for geriatric centers. Through its subsidiary Inmobiliaria Catharsis SA, the Company is also active in the Real State sector. Prim SA is a parent of Grupo Prim, a group which comprises such a number of controlled entities as Enraf Nonius Iberica SA, Establecimientos Ortopedicos Prim SA, and Luga Suministros Medicos SL, among others.

Contact Info

Calle F

numero 15., Polig. Industrial numero 1

+34.913.342400

https://www.prim.es/

Executive Leadership

Andres Estaire Alvarez

Executive Chairman of the Board

Enrique Gimenez-Reyna Rodriguez

Second Vice Chairman of the Board

Jose Luis Meijide Garcia

First Vice Chairman of the Board

Esperanza Deza Anta

Chief Financial Officer

Carlos Velasco Iglesias

Director

Key Stats

Price To Earnings (TTM)
17.01
Price To Sales (TTM)
1.41
Price To Book (MRQ)
1.91
Price To Cash Flow (TTM)
12.43
Total Debt To Equity (MRQ)
8.86
LT Debt To Equity (MRQ)
5.58
Return on Investment (TTM)
10.87
Return on Equity (TTM)
8.38

Latest News

Latest News

BRIEF-Prim Sells Minority Stake In Network Medical To For GBP 0.8 Mln

* SAYS SELLS MINORITY STAKE IN NETWORK MEDICAL TO SCP MEDICAL HOLDINGS (UK) LIMITED FOR GBP 0.8 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Prim FY EBITDA Up 17.5 Pct At 17.7 Mln Euros YoY

* FY NET PROFIT 13.9 MILLION EUROS VERSUS 13.1 MILLION EUROS YEAR AGO

BRIEF-Prim To Pay 2017 Gross Dividend Of 0.11 Euros Per Share

* TO PAY 2017 GROSS DIVIDEND OF 0.11 EUROS PER SHARE ON JAN. 16 2018 Source text for Eikon:

BRIEF-Prim Buys Anota SA

* BUYS ANOTA SA FOR 1.23 MILLION EUROS PLUS VARIABLE PART SUBJECT TO RESULTS OF ACQUIRED COMPANY IN 2019-2021 Source text for Eikon:

BRIEF-Prim 9-month net profit rises to 8.4 mln euros YoY

* 9-MONTH NET PROFIT 8.4 MILLION EUROS VERSUS 7.7 MILLION EUROS YEAR AGO

BRIEF-Medovex Corp ‍announced that it has launched its DenerveX System device in Spain with distributor Prim SA​

* Medovex Corp - announced that it has launched its DenerveX System device in Spain with distributor Prim SA Source text for Eikon: Further company coverage:

BRIEF-Prim H1 net profit up at 6.7 mln euros

* H1 NET PROFIT 6.7 MILLION EUROS VERSUS 5.7 MILLION EUROS YEAR AGO

BRIEF-Prim to pay 0.40 euro per share gross complementary dividend

* APPROVES TO PAY 0.40 EURO PER SHARE GROSS COMPLEMENTARY DIVIDEND ON JULY 18 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Prim sells stake in Saarema for 5 mln euros

* SAYS SELLS STAKE IN SAAREMA SOCIEDAD PROMOTORA DE CENTROS RESIDENCIALES (SAAREMA) FOR 5.0 MILLION EUROS

BRIEF-Prim to merge with its unit Enraf Nonius Iberica

* SAYS TO MERGE WITH ITS UNIT ENRAF NONIUS IBERICA S.A.U Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Prim Q1 net profit up at 2.9 mln euros

* Q1 REVENUE 30.3 MILLION EUROS VERSUS 26.1 MILLION EUROS YEAR AGO

BRIEF-Prim FY EBITDA up 13 pct YoY

* Said on Tuesday FY net sales 110.1 million euros ($116.0 million) versus 99.2 million euros year ago

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up